Insider Selling: SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells 3,670 Shares of Stock

SI-BONE, Inc. (NASDAQ:SIBN) insider Anthony J. Recupero sold 3,670 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $13.90, for a total value of $51,013.00. Following the completion of the transaction, the insider now directly owns 222,814 shares in the company, valued at $3,097,114.60. This trade represents a 1.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

SI-BONE Trading Down 1.1 %

Shares of NASDAQ SIBN traded down $0.15 during trading hours on Monday, hitting $14.12. 231,586 shares of the company traded hands, compared to its average volume of 251,762. The company has a current ratio of 8.25, a quick ratio of 7.22 and a debt-to-equity ratio of 0.22. SI-BONE, Inc. has a 12 month low of $11.70 and a 12 month high of $21.64. The stock has a market capitalization of $592.16 million, a price-to-earnings ratio of -15.35 and a beta of 1.16. The company’s 50 day moving average price is $13.58 and its 200 day moving average price is $14.14.

Hedge Funds Weigh In On SI-BONE

Several hedge funds have recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. grew its stake in shares of SI-BONE by 222.5% during the third quarter. Harbor Capital Advisors Inc. now owns 620,490 shares of the company’s stock valued at $8,674,000 after buying an additional 428,110 shares during the last quarter. American Century Companies Inc. boosted its holdings in SI-BONE by 22.8% during the 2nd quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock valued at $25,685,000 after acquiring an additional 368,637 shares during the period. Champlain Investment Partners LLC grew its position in SI-BONE by 14.7% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,800,073 shares of the company’s stock valued at $39,145,000 after acquiring an additional 358,821 shares during the last quarter. Paradigm Capital Management Inc. NY grew its position in SI-BONE by 24.7% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,349,400 shares of the company’s stock valued at $17,448,000 after acquiring an additional 267,100 shares during the last quarter. Finally, Impax Asset Management Group plc increased its stake in SI-BONE by 41.3% in the third quarter. Impax Asset Management Group plc now owns 758,521 shares of the company’s stock worth $10,604,000 after purchasing an additional 221,604 shares during the period. 98.11% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

SIBN has been the subject of a number of research analyst reports. Truist Financial lifted their target price on shares of SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Needham & Company LLC reiterated a “buy” rating and set a $19.00 price objective on shares of SI-BONE in a research report on Wednesday, November 20th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $23.00.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.